This latest FDA clearance should pave the way for the launch of the company’s Smart MDI system, which combines the InPen ...
The move marks a rare action by the FDA to sanction a study on cannabis despite the plant’s current Schedule I classification ...
The U.S. Food and Drug Administration approved Jazz Pharmaceuticals' drug, zanidatamab-hrii, for the treatment of a type of ...
The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.
Oncolytic viruses are a very promising class of therapeutic agents, with a broad range of types. In this exclusive interview ...
Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...
Experts view BridgeBio’s acoramidis—which has an FDA action date of Nov. 29—as either similar to or incrementally better than ...
The results pave the way for our multicenter phase 2 study in DIPG ... investors sued Y-mAbs for misleading about the FDA approval. Resolving The Case To resolve the lawsuit from investors, Y-mAbs has ...
The U.S. Food and Drug Administration approved PTC Therapeutics' gene therapy to treat a potential fatal enzyme deficiency ...